Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

GoodRx vs Push Health

GoodRx costs $801 less a month.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GoodRx logo

GoodRx

6.9
★★★★☆3.5/5

Best for: oral orforglipron alongside the injectables

Visit GoodRx →
VS
Push Health logo

Push Health

5.6
★★★☆☆2.8/5

Best for: semaglutide from $950/month

Visit Push Health →

If you are choosing between GoodRx and Push Health, the first difference is cost: GoodRx is $801 a month cheaper at the entry price. GoodRx leads our six-part score, 6.9 to 5.6.

GoodRx vs Push Health price

GoodRx is the cheaper way in: $149 a month against $950 a month at Push Health. That is $801 less each month (84% lower), or about $9,612 over a year of treatment.

Medications and formats

GoodRx and Push Health do not overlap on medication; only GoodRx lists tirzepatide and orforglipron; only Push Health lists semaglutide.

On format they match: each offers brand-name pens.

Where each one treats patients

GoodRx lists 50 states, and Push Health does not publish where it ships.

Pricing

GoodRx

Foundayo (lowest dose, self-pay)Brand-name
$149/mo
orforglipron
Zepbound KwikPen (self-pay)Brand-name
$299/mo
tirzepatide

Push Health

PreliminaryBrand-name
$950/mo
semaglutide

Ozempic / brand

What each price covers

Neither GoodRx nor Push Health spells out what its price covers, so ask whether the visit, the drug and shipping are all in the monthly figure.

Where each one scores higher

Overall, GoodRx scores 6.9 and Push Health 5.6 out of 10.

GoodRx is stronger on effectiveness (10.0 vs 9.0), user experience (5.0 vs 3.0), trust & safety (6.0 vs 4.0) and accessibility (10.0 vs 5.0).

Value and support are within half a point.

How we score

GoodRx

6.9/10

Overall

Push Health

5.6/10

Value25%

5.0A
vs
B
5.3

Effectiveness25%

10.0A
vs
B
9.0

User Experience15%

5.0A
vs
B
3.0

Trust & Safety15%

6.0A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

5.0A
vs
B
5.0

FDA warning letters

Neither GoodRx nor Push Health has an FDA warning letter on record with us.

Features & Coverage

FeatureGoodRxPush Health
Starting Price✓$149/mo$950/mo
Features✓6 features5 features
States Available50Not disclosed
Compounded——
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About GoodRx

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.

Read our full GoodRx review →

About Push Health

A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.

Read our full Push Health review →

Pros & Cons

GoodRx

What we like

  • Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
  • Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • Serves all 50 states
  • We found no FDA warning letters issued to GoodRx

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Push Health

What we like

  • Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
  • We found no FDA warning letters issued to Push Health

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: GoodRx

GoodRx wins this one, 6.9 to 5.6, above all for oral orforglipron alongside the injectables. It also costs $801 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.

Choose GoodRx if…

You want oral orforglipron alongside the injectables and an opening price near $149 a month.

Choose Push Health if…

You want semaglutide from $950/month and an opening price near $950 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

7.7

HealthRX

Compounded semaglutide at $133/month

GoodRx vs Push Health: FAQ

GoodRx. It starts at $149 a month; Push Health starts at $950 a month, $801 more per month.
No. GoodRx lists orforglipron and tirzepatide; Push Health lists semaglutide.
GoodRx lists 50 states; Push Health does not publish where it ships. Confirm your state before paying.
Neither says. Ask GoodRx and Push Health for an itemized monthly total.
GoodRx has none. Push Health has none.
No. Neither GoodRx nor Push Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.